Guest guest Posted September 23, 2004 Report Share Posted September 23, 2004 Hi folks: " CRP levels decreased 10% in the placebo group, 33% in the statin group and 28% in the modified-diet group " http://www.newhope.com/news.cfm?news=1355 (They forgot to mention over 80% with CRON. LOL - Hollosz/WUSTL) Rodney. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 23, 2004 Report Share Posted September 23, 2004 My CRP was measured in 1992 when I weighed 234# and it was negative. That could be the result of NSAIDS I was taking. Maybe it's higher on women. The don't want to check it anymore because they can't treat it. Braunwald: Heart Disease: A Textbook of Cardiovascular Medicine, 6th ed., "INFLAMMATION (see also Chap. 31) . Inflammation is increasingly recognized as a risk factor for CAD in women. In the Women's Health Study, C-reactive protein was as powerful an independent predictor as any other single factor.[52A] [52B] Women with the highest quartile of C-RP had a fivefold to sevenfold increased risk of cardiac and vascular events over a 3-year follow-up period. Other markers with lower, but still significant, risk include serum amyloid A, soluble intercellular adhesion molecule-1, and interleuken 6." 52A. Ridker PM, Hennekens CH, Buring JE, Rifai NC: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836–843, 2000. 52B. Ridker PM, Buring JE, Shih J, et al: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731–733, 1998 In particular, nearly half of all instances of myocardial infarction in the United States occur among individuals without overt hyperlipidemia.[4] Thus, this chapter also reviews in detail a series of novel atherosclerotic risk factors, including homocysteine, fibrinogen, and lipoprotein(a) (Lp[a]), as well as indices of fibrinolytic function (e.g., tissue-type plasminogen activator [t-PA] and plasminogen activator inhibitor 1 [PAI-1]) and markers of inflammation (e.g., high-sensitivity C-reactive protein (hs-CRP). Strategies for reducing coronary risk, often through modification of the factors outlined here, are provided in Chapter 32 and the pharmacotherapy of lipid disorders is dealt with more specifically in Chapter 33 . regards. ----- Original Message ----- From: Rodney Sent: Thursday, September 23, 2004 1:30 PM Subject: [ ] Reducing C-rp Hi folks:"CRP levels decreased 10% in the placebo group, 33% in the statin group and 28% in the modified-diet group"http://www.newhope.com/news.cfm?news=1355(They forgot to mention over 80% with CRON. LOL - Hollosz/WUSTL)Rodney. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.